Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata
- PMID: 8389723
- PMCID: PMC1195041
- DOI: 10.1136/sti.69.2.112
Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata
Abstract
CASE REPORT--SUBJECTS--Three cases are described of long-standing vaginal candidosis due to Candida glabrata. These had failed to respond to local and systemic antifungals. In each case the infecting strain appeared resistant to a range of azole drugs in vitro. CLINICAL COURSE--Case one--This patient recovered following prolonged treatment with oral itraconazole in combination with oral and vaginal nystatin. Case two. Yeasts were eradicated from this patient following cyclical treatment with oral dydrogesterone; prolonged vaginal treatment with nystatin may have helped. Case three. This patient did not respond to a prolonged course of oral itraconazole in combination with vaginal and oral nystatin, oral medroxyprogesterone or intravaginal boric acid. Eradication of C glabrata was finally achieved by local application of 1% gentian violet. Shortly after eradication of the C glabrata infection, both Case two and Case three developed infections with other Candida species responsive to azole antifungals.
Similar articles
-
Guideline: vulvovaginal candidosis (AWMF 015/072), S2k (excluding chronic mucocutaneous candidosis).Mycoses. 2015 Mar;58 Suppl 1:1-15. doi: 10.1111/myc.12292. Mycoses. 2015. PMID: 25711406
-
[INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].Akush Ginekol (Sofiia). 2016;55(4):20-29. Akush Ginekol (Sofiia). 2016. PMID: 29370489 Bulgarian.
-
Analysis of the risk factors associated with the emergence of azole resistant oral candidosis in the course of HIV infection.J Antimicrob Chemother. 1996 Oct;38(4):691-9. doi: 10.1093/jac/38.4.691. J Antimicrob Chemother. 1996. PMID: 8937963 Clinical Trial.
-
Fluconazole and itraconazole for vulvo-vaginal candidosis.Drug Ther Bull. 1990 Jan 22;28(2):7-8. Drug Ther Bull. 1990. PMID: 1966679 Review. No abstract available.
-
Chronic vulvovaginal candidosis: the role of oral treatment.Br J Clin Pract Suppl. 1990 Sep;71:81-4. Br J Clin Pract Suppl. 1990. PMID: 1965421 Review.
Cited by
-
The effect of gentian violet on virulent properties of Candida albicans.Mycopathologia. 2010 Apr;169(4):279-85. doi: 10.1007/s11046-009-9258-9. Epub 2009 Nov 24. Mycopathologia. 2010. PMID: 19937129
-
Influence of ovarian hormones on urogenital infection.Sex Transm Infect. 1998 Feb;74(1):11-9. doi: 10.1136/sti.74.1.11. Sex Transm Infect. 1998. PMID: 9634294 Free PMC article. Review.
-
In vitro activity of antimycotic agents determined by E-test method against vaginal Candida species.Mycopathologia. 1998-1999;144(1):15-20. doi: 10.1023/a:1006928628550. Mycopathologia. 1998. PMID: 10422269
-
Screening protocol for Torulopsis (Candida) glabrata.J Clin Microbiol. 1996 Sep;34(9):2300-3. doi: 10.1128/jcm.34.9.2300-2303.1996. J Clin Microbiol. 1996. PMID: 8862605 Free PMC article.
-
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections.Drugs. 1996 Apr;51(4):585-620. doi: 10.2165/00003495-199651040-00006. Drugs. 1996. PMID: 8706596 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources